Taylor 2003.

Methods	Randomised trial
Participants	81 patients enrolled; 69 high‐risk patients reported (intervention 33; control 36). 3 community‐based family medicine clinics affiliated with the University of Alabama School of Medicine—Tuscaloosa Alabama, USA Year of study: December 1998 to not stated.
Interventions	Intervention received usual care alongside pharmacotherapeutic interventions by a pharmacists. Meeting with pharmacist 20 minutes before physician; identifying and preventing problems related to drug therapy. Pharmacist made recommendations to physicians and provided drug and disease information. Written materials and devices to improve compliance were provided.
Outcomes	SF‐36 (physical functioning) at 12 months
Notes	Funding source: ASHP Research and Education Foundation Conflict of interest: Not stated
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Unclear risk	Method of randomisation not stated Quote: "Patients were randomly assigned to a control group or an intervention group".
Allocation concealment (selection bias)	Unclear risk	Not stated
Blinding of participants and personnel (performance bias) All Outcomes/Outcome 1	Unclear risk	Patients and personnel not blinded and potential for performance bias exists
Blinding of outcome assessment (detection bias) All Outcomes/Outcome 1	High risk	SF‐36 with no blinding
Incomplete outcome data (attrition bias) All outcomes	Low risk	Between group attrition < 10%. Overall completion rate > 80%.
Selective reporting (reporting bias)	Low risk	All outcomes reported
Other bias	Low risk	None identified